As per SNS Insider, the Global IVF Devices and Consumables Market is projected to reach USD 15.72 billion by 2035, growing at a 16.8% CAGR, while the U.S. market is projected to reach USD 4.65 billion, advancing at 16.5% CAGR, as AI-driven embryo grading and time-lapse imaging replace subjective assessment in fertility laboratories.

Austin, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- The IVF Devices and Consumables Market was valued at USD 3.33 billion in 2025 and is projected to reach USD 15.72 billion by 2035, registering a CAGR of 16.8% during 2026–2035. The market’s growth is attributed to increased infertility among people worldwide due to delayed conception and the impact of lifestyle choices, coupled with greater use of sophisticated fertility technologies. The importance of culture media, cryopreservation systems, time-lapse incubators that can take pictures of embryos, and AI-based embryo selection tools is increasing in fertility clinics.


Download the IVF Devices and Consumables Market Sample Report: https://www.snsinsider.com/sample-request/11030

The U.S. IVF Devices and Consumables Market was valued at approximately USD 1.01 billion in 2025 and is projected to reach approximately USD 4.65 billion by 2035, registering a CAGR of approximately 16.5% during 2026–2035. The market growth can be attributed to the presence of high-density fertility clinics, increased employer-based fertility coverage, increased awareness among patients, and use of time-lapse incubation and AI-based embryo selection systems. Increasing number of egg freezing services and fertility preservation centers are also contributing to steady demand for vitrification devices and laboratory instruments.

Why this Market is Gaining Attention in 2026

Rising Infertility and Advanced Embryo Assessment Are Increasing Demand for Assisted Reproductive Technology

The IVF tools and supplies are getting highly relevant due to rising cases of infertility as well as growing numbers of people who opt for assisted reproductive procedures and fertility preservation. The increased use of technologies, such as time-lapse imaging, vitrification, and AI-based embryo analysis helps to monitor embryos better and make more evidence-based decisions regarding transfers. At the same time, the expanded insurance and corporate fertility coverage provides more access to treatment services.

Commercial Findings from the IVF Devices and Consumables Market

IVF Consumables Dominated While IVF Devices Are the Fastest-Growing Product Type: IVF Consumables constituted 60% of the market share in 2025 owing to the repeated need for culture media, embryo transfer catheters, cryopreservation straws, and vitrification kits in each treatment cycle. The segment of IVF Devices is the fastest-growing category of products, driven by the increasing investment in time-lapse incubators, micromanipulators, and embryo imaging instruments integrated with artificial intelligence (AI).

Conventional IVF Led Technology While Time-Lapse Imaging is Growing Fastest: Traditional IVF made up 55% of the market in 2025, driven by well-proven clinical practices and relatively easy access to this method of infertility treatment. Time-lapse Imaging Technology is one of the most rapidly developing segments, since continuous embryo observation provides morphokinetic information without disrupting the culture conditions. AI is already used to enhance embryo viability assessment.

Assisted Reproductive Technology Dominated Applications While Research and Academic Institutes Are Expanding Fastest: ART was responsible for 75% of the market in 2025 owing to its key importance in both traditional and IVF-based, intracytoplasmic sperm injection as well as other clinical fertility processes. The Research & Academic Institutes is the fastest growing end-use category owing to increasing usage of IVF technology in understanding embryo development, genetic screening and fertility preservation process.

Fertility Clinics Led End Users While Cryobanks and Fertility Preservation Centers Are Growing Fastest: The share of Fertility Clinics was 58% in 2025 due to its position as the major site of care for IVF procedures and related lab activities. The growth rate of Cryobanks and Fertility Preservation Centers is the highest among all other end-users owing to the growing popularity of egg freezing and fertility preservation for the future.

North America Led the Market While Asia Pacific is Expected to Grow Fastest: North America had captured nearly 35.5% share in the global IVF Devices and Consumables Market owing to well-established infrastructure for fertility clinics, employer-sponsored fertility care, and quick embracement of sophisticated technologies for embryo evaluation. Asia Pacific region is expected to witness the highest growth rate at around 20.5% CAGR in the forecast period of 2026-2035 owing to increasing infertility rates and medical tourism among others.

Do you have any specific queries or need any customized research on IVF Devices and Consumables Market? Schedule a Call with Our Analyst Team: https://www.snsinsider.com/enquiry/11030

Who Should be Watching the IVF Devices and Consumables Market?

The market is increasingly relevant across the fertility treatment and reproductive-healthcare ecosystem, including:

Fertility clinics → IVF laboratories → cryobanks → reproductive endocrinologists → embryologists → fertility preservation centers → medical device manufacturers → laboratory consumable suppliers → healthcare providers → reproductive research institutes

Opportunities for providers of IVF technology exist in many different forms of culture media, embryo transfer consumables, vitrification devices, incubators, micro-manipulation tools, and artificial intelligence imaging systems. For fertility clinics and healthcare providers, purchase decisions are increasingly being driven by embryo survival, efficiency of workflow, consistency within laboratories, predictive accuracy of implantation, and improvements in patient access to advanced reproduction technology.

AI Integration and Fertility Technology Development Shape the 2026 Market

The investment in embryo grading technology using artificial intelligence, time-lapse imaging, and fertility preservation facilities has impacted the functioning of laboratories involved in assisted reproductive technologies. The development of the market has been geared towards enhancing the consistency of embryo grading, eliminating subjective choices made during the process.

  • In 2025, Esco Medical continued expanding clinical adoption of its Miri Time-Lapse Incubator, integrating AI-based embryo grading software to support fertility clinic embryology workflows.
  • In 2025, INVO Bioscience, Inc. continued expanding commercial availability of its INVOcell intravaginal culture device, offering a lower-cost alternative to conventional laboratory-based IVF incubation.

Market Challenge: High Treatment Costs and Regulatory Complexity Constrain Expansion

IVF therapy is expensive to many patients, especially in healthcare systems where fertility treatments are not reimbursed at all. The expense of the treatments, the laboratory instruments, and other materials required for conducting treatments may prevent access to advanced treatments, with larger facilities and financially capable individuals being more likely to have access to such treatments.

Other barriers facing the market include regulatory frameworks that vary from one jurisdiction to another for embryonic research, donor gametes, and cross-border reproduction services. Variations in regulations make the introduction and use of new technology difficult in less developed markets.

Buy the IVF Devices and Consumables Market Report with Competitive Analysis at a 20% Discount: https://www.snsinsider.com/checkout/11030

Key Competitors in the Market

Companies covered in the IVF Devices and Consumables Market research include CooperSurgical, Inc. (The Cooper Companies), Vitrolife AB, Merck KGaA, Thermo Fisher Scientific Inc., FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Hamilton Thorne Ltd., Esco Medical, Genea Biomedx, INVO Bioscience, Inc., Cook Medical LLC, Rocket Medical Plc, Nidacon International AB, Memmert GmbH + Co. KG, KITAZATO Corporation, IVFtech ApS, BIOPSYBELL Srl, Cryo Bio System, Shenzhen VitaVitro Biotech Co., Ltd., Progyny, Inc., and Ferring Pharmaceuticals A/S.

CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com